ACPMP - Appendix Cancer / Pseudomyxoma Peritonei Research Foundation

01/30/2026

Last year, a team of peritoneal surface malignancy and cancer researchers at Yale School of Medicine launched the DECISIVE study to comprehensively characterize the decision-making experiences of individuals and their caregivers considering cytoreductive surgery. Over 140 people with cancer and care partners, including many from ACPMP, generously gave their time and energy to sharing their PMP and related cancer journeys, going beyond clinically-oriented outcomes like complications and costs, to shine a light on experiences like the struggles of self-advocacy in obtaining a diagnosis, the challenges of finding a medical team, the work needed to prepare and recover for surgery, and how it affected day-to-day lives and priorities.

After a year of analysis, they are pleased to present updates on their findings and a look ahead to what comes next for the DECISIVE team as they work to build decision aids and resources for individuals and their loved ones considering cytoreductive surgery and the clinicians caring for them.

There will be a live Q&A session with Dr. Elizabeth Godfrey and Dr. Nicole Aguirre after the presentation.

01/29/2026

Join us at 7 PM ET tonight for HIPEC vs PIPAC: Exploring a New Clinical Trial for Appendix Cancer Patients Not Eligible for Cytoreductive Surgery.

There's still time to register! All registrants will receive the webinar recording, even if you are unable to attend live.

Register: https://acpmp.org/hipecvspipac

01/28/2026

is coming up in one month: February 28! 💙

Join us in raising awareness for appendix cancer and other rare cancers.

Learn how you can make a difference: https://acpmp.org/get-involved/

01/28/2026

Join us tomorrow, January 29 at 7 PM ET for HIPEC vs PIPAC: Exploring a New Clinical Trial for Appendix Cancer Patients Not Eligible for Cytoreductive Surgery.

Patrick Wagner, MD, and Shannon Altpeter, PA-C, will walk through the purpose and structure of CHARLIE’S Trial 2 and the key questions the study aims to answer.

A live Q&A session will follow the presentation to address attendees' questions. Free & open to all.

Register: https://acpmp.org/hipecvspipac

01/26/2026

Can’t join us live this Thursday, January 29? Register to receive the recording!

Everyone who signs up for "HIPEC vs PIPAC: Exploring a New Clinical Trial for Appendix Cancer Patients Not Eligible for Cytoreductive Surgery" will receive same-day access to the full webinar recording once it’s complete.

Register today: https://acpmp.org/hipecvspipac

01/23/2026

For patients with appendix cancer who are not eligible for cytoreductive surgery, treatment options can feel limited. That’s why research like CHARLIE’S Trial 2 is so important.

Join us January 29 at 7 PM ET for a free webinar comparing HIPEC and PIPAC and exploring what this new clinical trial could mean for patients with peritoneal disease.

Presented by Patrick Wagner, MD, and Shannon Altpeter, PA-C, of Allegheny Health Network.

Register today: https://acpmp.org/hipecvspipac

01/22/2026

New research shows just how powerful personalized cancer treatment can be.

A landmark clinical trial led by researchers at UC San Diego found that tailoring cancer treatments to the unique DNA of each patient’s tumor significantly improved outcomes, without increasing severe side effects.

Instead of a one-size-fits-all approach, this study used detailed molecular profiling to guide individualized drug combinations, bringing precision oncology closer to everyday clinical care.

The findings were published in the Journal of Clinical Oncology and offer real hope for more effective, patient-centered cancer treatment.

Read more:

Researchers at University of California San Diego School of Medicine have led the first clinical trial in the world to show that cancer drug treatments can be safely and effectively personalized based on the unique DNA of a patient's tumor.

01/21/2026

Happy World Hugging Day! 🤗

A hug isn’t just comforting. It can lower stress, boost your mood and even support your immune system.

Spread a little love today and feel the power of connection 💙

01/20/2026

SAVE THE DATE: Join us for a free webinar on February 26, 2026 at 7PM for a 1-year update on the DECISIVE study.

Last year, a team of peritoneal surface malignancy and cancer researchers at Yale launched the DECISIVE study to comprehensively characterize the decision-making experiences of individuals and their caregivers considering cytoreductive surgery. Over 140 people with cancer and care partners, including many from ACPMP, generously gave their time and energy to sharing their PMP and related cancer journeys, going beyond clinically-oriented outcomes like complications and costs, to shine a light on experiences like the struggles of self-advocacy in obtaining a diagnosis, the challenges of finding a medical team, the work needed to prepare and recover for surgery, and how it affected day-to-day lives and priorities.

After a year of analysis, they are pleased to present updates on their findings ahead of submission for publication and a look ahead to what comes next for the DECISIVE team as they work to build decision aids and resources for individuals and their loved ones considering cytoreductive surgery and the clinicians caring for them.

There will be a live Q&A session with Dr. Elizabeth Godfrey and Dr. Nicole Aguirre after the presentation.

REGISTRATION COMING SOON!

01/20/2026

Many patients with appendix cancer are not candidates for cytoreductive surgery, leaving limited treatment options. There is a great need to expand alternatives for this patient population.

On January 29 at 7 PM ET, join us for HIPEC vs PIPAC: Exploring a New Clinical Trial for Appendix Cancer Patients Not Eligible for Cytoreductive Surgery, a free webinar introducing CHARLIE’S Trial 2.

Led by Patrick Wagner, MD, and Shannon Altpeter, PA-C, of Allegheny Health Network, this session will cover the study's purpose, structure, and the questions it aims to answer.

Register today: https://acpmp.org/hipecvspipac

01/18/2026

Appendix cancer doesn’t fit neatly into broader cancer research, which is why targeted, disease-specific studies matter. Through strategic funding, we focus on research that addresses unanswered questions and drives progress for this rare cancer.

🔬 Learn more about funded research: https://acpmp.org/research/research-grants-awarded/

01/15/2026

📅 Mark Your Calendars!

The 20th Anniversary Appendix Cancer Global Walk takes place June 13–21, 2026.

Join us as we mark 20 years of raising awareness, fueling research, and standing with everyone affected by appendix cancer.

Early registration opens February 1.